This study gives continued access to a medicine called mitapivat for people who already participated in a previous study by Agios, a company that sponsored the research. Mitapivat is a drug that participants were already taking and found beneficial. If you are a woman who can have children, you must not get pregnant and should use two types of birth control during the study and for 28 days after.
To join, you must have been part of a previous Agios study and found the medicine helpful. You also need to agree not to join any other medical studies while taking part in this one. You must not be allergic to mitapivat and should have no medical conditions that the study doctor thinks would make it risky for you.
Key Points:
- Participants continue with their current mitapivat dose.
- Women must use two forms of birth control.
- Cannot join other clinical studies during this one.
How understandable was the trial content above?
Hard to understand
Easy to understand